Dr. David Roger Benavides, MD, PhD

Dr. Benavides practices at University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System.

Dr. Benavides' NPI, 1609194885, was assigned on May 12, 2010. Dr. Benavides graduated from University of Texas Southwestern Medical School at Dallas in 2010. Dr. Benavides holds Maryland license D77507.

Dr. Benavides' primary practice is University of Maryland Medical Center, at 22 South Greene Street, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 328-8667.

Dr. Benavides' primary practice is University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System. The medical group on file is University of Maryland Neurology Associates, P.A. Dmand AI also links Dr. Benavides to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Benavides practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Benavides' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Benavides is licensed in Maryland.

CMS data shows 77 Medicare services from Dr. Benavides across 3 procedure codes in 2024, for 76 Medicare patients. Medicare paid $7,479 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 76 Medicare patients who saw Dr. Benavides in 2024. The largest group is 65 to 74, with 26 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 36% are also on Medicaid. Their average risk score is 2.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Benavides' median patient age at 55, with 68% women.

In 2024, Dr. Benavides wrote 112 Medicare Part D claims for 18 patients. 86% of them were for generic drugs. CMS names the drug for 87 of them, across 5 drugs with 11 or more claims each, at $197,397 in total drug cost. In 2023, CMS named 83 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Benavides for performance year 2024, reported as part of a group. Dr. Benavides accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 21 papers to Dr. Benavides, published from 2011 to 2022. 2015 was the busiest year, with 4. The most frequent topics are Encephalitis, Anti-N-Methyl-D-Aspartate Receptor Encephalitis and Autoimmune Diseases. Dr. Benavides has published most often in J Biol Chem. Dr. Benavides' most frequent co-authors are Arun Venkatesan, MD, Hesham Ahmed Abboud, MD and Eoin Paul Flanagan, MBCHB.

CMS Open Payments shows 24 general payments to Dr. Benavides from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Providence Medical Technology, Inc. paid the most, $487.

Dr. Benavides graduated from University of Texas Southwestern Medical School at Dallas in 2010.